You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition

 

Online download statistics by month:

Online download statistics by month: October 2023 to September 2025

AbstractFullPdf
Oct 2023471473189
Nov 202313813937
Dec 2023899140
Jan 2024717135
Feb 202411911959
Mar 2024177178141
Apr 2024175176125
May 202414314798
Jun 202414514695
Jul 2024161162121
Aug 202412312489
Sep 2024144143113
Oct 202415615692
Nov 2024163165116
Dec 2024193199103
Jan 202514414593
Feb 2025316316121
Mar 2025162162123
Apr 202515415496
May 202511511582
Jun 2025979752
Jul 2025110
Sep 2025110
Total345834802020